- Belgian med-tech company SamanTree Medical lands InvestEU-backed financing to boost research, development and innovation of advanced microscopy scanner tech.
- SamanTree’s advanced microscopy scanner allows rapid, real-time imaging of internal microstructures of tissue samples for surgical procedures, notably for breast cancer.EIB-funding will accelerate development of the Histolog® Scanner and reinforce commercialisation efforts across Europe and United States.
SamanTree Medical, a European leader in surgical imaging innovation, has secured €20 million in financing from the European Investment Bank (EIB). The operation is backed by InvestEU, the EU’s flagship program to mobilize over €372 billion in additional investment from 2021 to 2027.
The financing supports the development of an advanced confocal microscopy scanner for rapid imaging of the internal microstructure of tissue samples during surgical procedures. Furthermore, the financing will support SamanTree Medical’s research, development and innovative activities, including continued development and advancement of its Histolog® Scanner, the first and only medical imaging device featuring massively parallel confocal microscopy.
The EIB financing is provided through the Bank’s Venture Debt Instrument and is designed to support highly innovative companies undertaking research-intensive development activities. By extending the company’s cash runway and de-risking its development plan, the financing is expected to help accelerate product development and reinforce SamanTree’s commercialization efforts across Europe and the United States.